STOCKHOLM, March 30, 2021 /PRNewswire/ --
IRRAS's annual report 2020 has today been published on the
company's website.
The report is available on:
https://investors.irras.com/en/reports-presentations
The financial year covers the period from 1 January to
31 December 2020.
About IRRAS
IRRAS is a global medical care company focused on innovative
medical solutions to improve the lives of critically ill patients.
IRRAS designs, develops, and commercializes neurocritical care
products that transform patient outcomes and decrease the overall
cost of care by addressing complications associated with current
treatment methodologies. IRRAS markets and sells its comprehensive,
innovative IRRAflow and Hummingbird ICP Monitoring product lines to
hospitals worldwide through its direct sales organization in
the United States and select
European countries as well as an international network of
distribution partners.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
USA
Kleanthis G. Xanthopoulos, Ph.D.
CEO
ir@irras.com
Europe
Sabina Berlin
CFO
+46 73 951 95 02
sabina.berlin@irras.com
The information was released for public disclosure, through
the agency of the contact person above, on March 30, 2020 at 8:30
p.m. (CET).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/irras/r/irras-publishes-annual-report-for-2020,c3316592
The following files are available for download:
https://mb.cision.com/Main/16550/3316592/1394634.pdf
|
IRRAS AB Annual
Report 2020
|